STD Webinars

Individual Webinars

Disease Intervention Specialist: Retention, Recruitment, and Training Meeting – January 13, 2022

This four-hour webinar focused on understanding the insights, challenges, possible resolutions, and costs related to maintaining a skilled disease intervention specialist (DIS) workforce. This webinar is a follow-up to the Enhancing Disease Investigation and Intervention Functions Meeting held September 8-10, 2021.

Enhancing Disease Investigation and Intervention Functions Meeting – September 8-10, 2021

Across three days, this virtual meeting unpacked characteristics of disease investigation and intervention functions in the context of public health priorities.

Enhancing Disease Investigation and Intervention Functions Meeting Day 1
Presentations on day one described the role of rules, regulations, accountability, cost benefit considerations and the organizational context and structure of DIS teams related to the effectiveness and impact of disease investigation and intervention

Enhancing Disease Investigation and Intervention Functions Meeting Day 2
Presentations on day two examined recently developed technologies, both digital and medical, and considered how they can be adapted to DIS work as well as performance metrics and outcome assessments as they shape DIS functions today and in the future

Enhancing Disease Investigation and Intervention Functions Meeting Day 3
Day three summarized the first two days of the webinar and included a panel discussion in which panelists answered questions related to DIS functions and their effectiveness and impact

Remote Health Meeting – May 24-25, 2021

This two-day webinar focused on optimizing delivery of sexual health services (STI and HIV) through communication technologies. The webinar explored perspectives and experiences from health departments, academia, industry, and CDC on the topic.

Remote Health Meeting Day 1

Remote Health Meeting Day 2

CDC 2021 Sexually Transmitted Infection (STI) Treatment Guidelines Update Webinar – December 18, 2020

Gail Bolan, M.D., Laura Bachmann, M.D, and Kim Workowski M.D., from the Division of STD Prevention (DSTDP), hosted an informational webinar to provide an overview of the proposed updates to CDC’s 2015 STD Treatment Guidelines. Discussions focused on:

  1. Changes to testing, management, and/or treatment recommendations for Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis;
  2. Role of metronidazole in pelvic inflammatory disease treatment;
  3. Alternative treatment options for bacterial vaginosis;
  4. Management of Mycoplasma genitalium; and
  5. Two step testing for serologic diagnosis of genital HSV-2.

During the webinar, CDC staff addressed questions and comments from partners, stakeholders and other interested parties. Comments and feedback made during the webinar will be considered prior to finalizing the updated STI Treatment Guidelines for publication.

ELC K8: Threat of Antibiotic Resistant Gonorrhea—Rapid Detection and Response Capacity  – April 8, 2016

This webinar provided an overview of the K8 ELC supplement, which is part of the larger Epidemiology and Laboratory Capacity for Infectious Diseases Funding Opportunity Announcement (FOA)external icon. The webinar focused on building epidemiologic, surveillance, and laboratory capacity to rapidly detect and respond to reduced-susceptibility and resistant gonorrhea and described Strategies and Activities specific to this FOA.

Participants also learned about CDC’s framework for these ideas, and will better understand how they relate to – yet are distinct from – other Division funding opportunities such as the Gonococcal Isolate Surveillance Project (GISP) and the STD Surveillance Network (SSuN).

Representatives from CDC’s Division of STD Prevention (DSTDP) responded to questions about the required and optional Activities that make up this epidemiologic, surveillance, and laboratory capacity-building FOA.

The Last Resort: Electronic Health Communication in North Carolina – September 23, 2015

Steve Beagle, Field Coordinator for the North Carolina Department of Health and Human Services,  presented a visual account of the evolution of partner services in North Carolina to reach previously untraceable clients, from email and web sites to text messaging and smart phone apps.

Report-Back and Update on the STD AAPPS Program Outcome Measures (POM) – June 23, 2015

Report-Back and Update on the STD AAPPS Program Outcome Measures (POM)

DSTDP Evaluation Team members Marion Carter and Dayne Collins presented the “Report-Back and Update on the STD AAPPS Program Outcome Measures (POM)” Webinar on June 23.  This two-part webinar included a presentation of findings from the March 2015 POM submissions, where presenters summarized statistics and comparisons across project areas and described plans for further dissemination. For the second part of the webinar, DSTDP staff outlined guidance and rationale for the upcoming August 2015 POM submission, including changes to existing POM as well as new POM.

NEDSS Base System STD Module Webinar July 24, 2014

This webinar demonstrated the new STD Module of the National Electronic Disease Surveillance System Base System (NBS).

NBS provides reporting jurisdictions with a NEDSS-compatible information system to facilitate transferring health, laboratory, and clinical data efficiently and securely over the Internet. The demo focused on case management and other STD-specific features of the NBS. Staff from CDC’s Division of Health Informatics and Surveillance answered questions about the NBS STD Module development and implementation.

Community Approaches to Reducing Sexually Transmitted Diseases FOA – March 6, 2014
CDC’s Division of STD Prevention hosted a webinar about the new Community Approaches to Reducing Sexually Transmitted Diseases (CARs) Funding Opportunity Announcement (FOA).

For the CARS cooperative agreement, CDC will work with organizations to promote sexual health, advance community wellness, influence sexual health behavior and practices, and reduce STI disparities. The FOA provides support in the following five focus areas:

  1. Implementation of community engagement methods (e.g. community-based participatory research) to achieve health equity;
  2. Identification and implementation of systems and environmental change strategies that (a) promote sexual health and support healthy behaviors and (b) facilitate community-clinical linkages to build support for interventions to prevent and reduce STI disparities;
  3. Enhancement and sustainability of partnerships;
  4. Support for communication strategies to promote STD program successes and leverage additional resources for STI control and prevention; and
  5. Evaluation of the efficacy of this approach and intervention implementation.

Third-Party Billing for Public Health STD Services: A Summary of Coordinated Needs Assessment – February 26, 2014
This webinar was based on information collected by the STD-related Reproductive Health, Prevention, Training, and Technical Assistance Centers. Andee Krasner, Region I STD TTAC Project Manager; Jennifer Kawatu, Region I STD TTAC Project Director; and Daryn Eikner, Director of Service Improvement at the Family Planning Council provided webinar participants with an overview of national data collected to better understand the current status and capacity for billing for STD services, training and technical assistance needs for STD-certified 340B clinics, state or project area STD programs, and state public health laboratories.

STD AAPPS Kickoff Meeting: Moving Forward in 2014 and Beyond – January 28, 2014
Staff from CDC’s Division of STD Prevention and the Procurement and Grants Office hosted “STD AAPPS Kickoff Meeting: Moving Forward in 2014 and Beyond,” a webinar for STD AAPPS grantees. Topics covered on this webinar included cooperative agreement monitoring, program consultant activities and assignments, PGO requirements, and how to request technical assistance.

Disease Intervention Services Training Centers FOA – November 8, 2013
Staff from CDC’s Division of STD Prevention and the Division of HIV/AIDS Prevention hosted a webinar about the new funding opportunity announcement (FOA) for STD/HIV Disease Intervention Services Training Centers (DISTC). CDC staff provided general information to applicants about the DISTC FOA.

Program Science: The Concept and Applications – August 20, 2013, Dr. Sevgi Aral, Associate Director of Science in CDC’s Division of STD Prevention provides webinar participants with general information about Program Science as a scientific focus; systems science as the core scientific discipline in Program Science; systems science methodologies; and Program Science Initiatives in the UK, Australia, and North America. Researchers, academia, and STD program staff will find this webinar of interest in their daily work.

Program evaluation, quality improvement, and performance management: Understanding how they relate and their role in public health programs – August 6, 2013, Presenters: Craig Thomas, Liza Corso, and Harold Pietz from CDC’s Office of State, Tribal, Local and Territorial Support (OSTLTS)

STD AAPPS Funding Opportunity Orientation, Q&A, and Evaluation – June 17 and 26 and July 11, 2013

The Revised Congenital Syphilis Report Form – What’s New, Why, and How to Use It – April 29, 2013 with John R. Su, MD, Phd, MPH

Reducing the Burden of HPV-associated Cancer and Disease through Vaccination in the US – CDC Public Health Grand Rounds – February 19, 2013

The Growing Threat of Multidrug-Resistant Gonorrhea – CDC Public Health Grand Rounds – May 15, 2012

2015 STD Treatment Guidelines Webinars

2015 CDC STD Treatment Guidelines Update Webinar in Spanish – April 5, 2016

Hosted by the NYC STD/HIV Prevention Training Center, the University of Washington STD Prevention Training Center, the National Network of STD Clinical Prevention Training Centers, and the Centers for Disease Control and Prevention.

Continuing medical and nursing education credits (CME/CNE) are available.

2015 STD Treatment Guidelines Overview Webinar – June 22, 2015

2015 STD Treatment Guidelines Overview Webinar

The STD Treatment Guidelines were developed through a rigorous peer-review process to assist clinicians and healthcare providers in giving their patients the appropriate STD testing, treatment, and counseling messages. The 2015 STD Treatment Guidelines were released in June, and included updated testing, treatment, and diagnosis recommendations. Please join this webinar hosted by the U.S. Centers for Disease Control and Prevention’s Division of STD Prevention and the National Network of STD/HIV Prevention Training Centers to learn about these key changes.

Continuing education credits are available for this webinar.  At the conclusion of the session, the participant will be able to accomplish the following:

  • Discuss clinical significance of the STD prevention issue.
  • Describe epidemiological trends related to the STD prevention issue.
  • Identify key screening, treatment, and prevention recommendations for management of the STD prevention issue.
  • Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

The CE credits offered are:

CME:  1.5 hours
CNE:  1.5 hours
CEU:  0.2 hours
CECH:  1.5 hours
CPE: 0.15 hours

Step-by-step instructions on how to obtain CE credit on TCEOnlinepdf icon

View Recordingmedia icon closed captioned

Webinar Slidespdf icon

Questions & Answers from the webinar (archived)

Program Development and Quality Improvement Webinar Series

STD AAPPS Program Outcome Measures: Highlights from the Sept 2014 Submission and Proposed Changes for the Future January 29, 2015

STD AAPPS awardees submitted their first set of program outcome measures to DSTDP in September 2014, covering the first 6 months of the award. Since then, the measures and initial results have been under review and minor and major changes are being planned for those measures. In this webinar, CDC staff shared highlights from that data submission. CDC staff also described the proposed changes, the rationale for changes, and what will be requested for March 2015 and beyond. CDC staff described the administrative requirements related to support for clinical preventive services under STD AAPPS, which CDC will request for March.

Assessing Partner Services as a Priority Intervention September 24, 2014

Dr. Matthew Hogben, Chief of the Social and Behavioral Research and Evaluation Branch, led the Partner Services assessment Webinar.

Those who attended the 2014 grantees meeting identified Partner Services as a priority intervention. As follow-up to this feedback, in this webinar Dr. Hogben will described a framework to assess partner services in STD control in 2014 – 2019.  He also presented an overview of the pertinent literature and a data snapshot from current programs to characterize the process and outcome indicators of some partner services programs.

Following the presentation there was a discussion about possible approaches to improving Partner Services.

STD-AAPPS Awardee Meeting Findings and Evaluation August 14, 2014

Dr. Jill Huppert, Program Development & Quality Improvement Branch (PDQIB) Branch Chief, and other DSTDP leadership presented the “STD-AAPPS Awardee Meeting Findings and Evaluation” webinar ton August 14, 2014. Presenters discussed findings and evaluation results from the STD-AAPPS awardee meeting sessions held at the 2014 STD Prevention Conference in June, 2014. Presenters shared a description of DSTDP’s plans to address the meeting findings and led a discussion of next steps to support STD-AAPPS outcomes. Webinar participants also had the opportunity to provide additional input regarding future AAPPS meetings.

Supplemental Funding Opportunity Announcement for STD AAPPS July 8, 2014

CDC’s Division of STD Prevention hosted a webinar on July 8, 2014 about the new supplemental funding opportunity announcement (FOA) to STD AAPPS. This supplement will support enhanced program evaluation in a limited number of project areas over the next few years. Eligibility is limited to current awardees of STD AAPPS. This supplemental FOA focuses on evaluation of one or more of the following program strategies:  1) Use of assessment data for program decision-making, 2) Increasing CT screening in primary care settings, 3) Use of DIS for HIV-related outcomes, and 4) DIS contributions towards STD prevention more generally.

For the webinar, CDC staff provided general information to applicants about the enhanced program evaluation AAPPS FOA supplement.

Update on STD AAPPS Program Outcome Measures May 8, 2014

CDC’s Division of STD Prevention (DSTDP), in collaboration with the National Coalition of STD Directors (NCSD) and various project areas, have been developing program outcome measures for STD AAPPS. DSTDP staff described changes made to the measures in response to feedback and presented the latest set for 2014.

STD AAPPS Laws and Policy for AAPPS Grantees April 10, 2014

CDC’s Division of STD Prevention (DSTDP) hosted a webinar, “Laws and policy for AAPPS grantees”, on Thursday April 10, 2014. Lori Elmore, Lydia Poromon, and Ryan Cramer from DSTDP’s Office of Policy, Planning and External Relations, presented the webinar.

The presenters described the difference between policy and lobbying, introduce policy activities and deliverables under AAPPS, and provided examples of activities from state and local programs. The presenters also characterized the fundamentals of federal, state, and local lawmaking and provided an overview of state statutes concerning the prevention of sexually transmitted diseases.

STD AAPPS Gap Analysis: Guidance and Toolkit Development, March 13, 2014

DSTDP leadership discussed the STD Service GAP Analysis tool, guidance development, pilot activities, and lessons learned and shared guidance and examples from the Program Collaboration and Service Integration (PCSI) GAP analysis.

Participants learned about recommended practices for performing STD Service GAP analysis. Representatives from DSTDP commented on how the presentation’s content applies to the work that will be performed by the Division and its partners.

Introduction to Awardee Evaluation Plans and National Outcome Measures for STD AAPPS, Rescheduled: February 20, 2014

DSTDP leadership and staff described STD AAPPS awardee requirements in the first year of that award. They also provided an update on national outcome measures for AAPPS.

Participants will learn about proposed guidance for the Awardee Evaluation Plans. Representatives from DSTDP commented on how the presentation’s content applies to the work that will be performed by the Division and its partners.

STD Prevention Science Series

Integration of molecular epidemiology with behavioral surveillance to identify HIV and HCV epidemic drivers in at risk populations: Lessons learned from Pakistan and Ukraine – September 7, 2017, by Paul Sandstrom, PhD,

The presentation focused on the use of bioinformatics tools to resolve HIV and HCV transmission dynamics in at risk populations in Pakistan and Ukraine. Specifically the identification of a previously underappreciated HIV epidemic amongst young women engaging in transactional sex work in Eastern Europe, as well hidden epidemic drivers in at risk populations (people who inject drugs and sex workers) in Pakistan.

 Conceptualizing Geo-Sexual Archetypes: Mapping the sexual travels and ego-centric sexual networks of gay and bisexual men in Toronto, Canada – June 8, 2017 by Dionne Gesink, PhD

There is a complex and persistent syphilis epidemic affecting gay, bisexual and other men who have sex with men (gbMSM) in every major urban centre across North America. Dr. Gesink described an initial exploration into the geography of sex, a necessary, yet understudied, aspect of STI transmission.


Transgender Health Disparities: Challenges and Opportunities STD Prevention Science Series – March 23, 2017 by Aron Janssen, MD

Dr. Aron Janssen described what we do and do not know about the mental health and medical needs of this population, and the structural barriers that make access to appropriate care difficult


French Disease to Ipergay: Syphilis networks in the PrEP era – January 26, 2017 by John Schneider, MD, MPH

Dr. John Schneider  described syphilis networks of the most at-risk populations in the United States and in particular, younger Black men who have sex with men. He presented comparisons of these networks with HIV networks and the implications of co-infection. Dr. Schneider contextualized both networks within the era of PrEP and described ongoing and novel network interventions to limit the impact of ongoing domestic syphilis epidemics.

A Journey through Syphilis: How does Treponema pallidum cause such a complex disease? – June 2, 2016 by Sheila Lukehart, PhD

Syphilis is a disease that comes and goes, with manifestations affecting many different organ systems. The clinical course is the result of interactions between the host’s immune response and the bacterium’s ability to overcome or evade that response, a duel that can last a lifetime. This presentation focused on our evolving understanding of these host and bacterial mechanisms, and their implications for syphilis control.

STDs, the Genital Microbiome and HIV Transmission: What is Happening Down There? – March 10, 2016 by Rupert Kaul, MD, PhD

Antiretroviral therapy (ART) dramatically reduces HIV transmission when used as treatment or as PrEP, but the global rate of new HIV infections currently outstrips our ability to provide ART. Most of these new HIV infections are acquired through sex, when the mucosal lining of the vagina, penis or rectum is exposed to HIV-infected genital fluids. Sexual HIV transmission is surprisingly inefficient, with a per-contact risk under 1% for most exposures. This presentation  focused on how this risk is dependent on the dynamic interaction between our immune system and microbes—both HIV, other STIs and the larger microbiome—at the mucosal surfaces of the genital tract and gut, and highlighted some challenges of translating these research findings into new HIV prevention strategies.

Comprehensive Sexual Health Care for Sexually and Gender Minority Patients in the HAART and PrEP Era – December 3, 2015 by Kenneth Mayer, MD

Sexual and gender minority patients have experienced sexual health disparities that are partially related to behaviors (e.g. frequent partner change among some subgroups), biology (e.g. increased susceptibility of the rectal mucosa to HIV and several other STIs), and structural factors (e.g. lack of culturally competent care, unsupportive socio-political environments). The advent of highly active antiretroviral therapy (HAART) and pre-exposure prophylaxis (PrEP) means that individuals can engage in condomless sex without HIV transmission. The implications of the new findings in HIV prevention for STI management and control were explored in this talk, with suggestions for the development of new paradigms to enhance the sexual health of these populations.

Risks and Resiliencies: HIV and STIs among Gay Men, other Men who have Sex with Men and Transgender Women Globally – September 3, 2015 by Stefan Baral, MD, MPH, FRCPC

The STD Prevention Science Series presented the results of recent systematic reviews of the burden of HIV and STIs among gay men, other men who have sex with men, and transgender women in both high and low and middle income settings. The webinar also included a discussion about the vulnerabilities that lead to adverse health outcomes among these populations.

Public Health in a Hostile Environment: Racial Inequality and STD/HIV in the US – June 4, 2015 by Adaora Adimora, MD, MPH

Public Health in a Hostile Environment: Racial Inequality and STD/HIV in the US

It’s now well understood that social factors are a major determinant of HIV and other STDs. But how can we develop relevant interventions? And what are the methodological challenges of social determinants research? This talk explored how these issues can impact STD epidemiologic research among African-Americans.

STDs Amplify the Transmission of HIV: Where do we go from here? – December 11, 2014, by Myron S. Cohen, M.D.

Since the time HIV was discovered as the cause of AIDS, we have known that a wide variety of STDs amplify transmission of the virus. The biological forces that create such risk are increasingly well understood. The greatest challenge has been to design strategies that link detection and treatment of STDs to reduced transmission of HIV.

This STD Prevention Science Series webinar explored that challenge.

From Partner Services to Field Services: The Evolving Role of Public Health Outreach to Control HIV/STDs – March 13, 2014, by Matthew Golden, MD
Dr. Golden spoke about the evolving role of public health out¬reach in HIV/STD. Partner services have been a component of public health STD control since the 1940s, but were not initially widely employed to combat the HIV epidemic and were never adequately funded to meaningfully affect rates of chlamydial infection. The advent of expedited partner therapy for gonorrhea and chlamydial infection, a new national emphasis on the HIV care continuum, and HIV/STD program integration are now fundamentally altering the role of disease investigation and outreach in the control of HIV/STD, both in the U.S. and in low income nations.

Dr. Golden’s talk presented evidence supporting an expanded role for field outreach in the control of HIV/STD and discussed outstanding operational research questions that confront this area of public health practice.

The Microbiome of the Penis in Adolescent Men – March 7, 2013
with J. Dennis Fortenberry, MD, MS

The Road From Observation to Intervention to Implementation: Perspectives of a Pragmatic HIV Prevention Researcher – December 13, 2012
with Connie Celum, MD, MPH

Contraception and STI/HIV: Balancing the Tradeoffs in Different Contexts – August 31, 2012
with Ward Cates, MD, MPH

  • View recording closed captioned This educational activity can now be accessed as an educational resource but CME credit is no longer available.

It’s Not Just the Pathogen Anymore: The Genital Microbiome and Implications for Sexually Transmitted Infections – July 6, 2012
with Jeanne Marrazzo, MD, MPH